Latest Quarter
2026-04-08
Lin BioScience Inc (6696.TWO)
Revenue
$0.0
Net Income
-$313M
Operating Margin
N/A
Free Cash Flow
-$1.0B
Debt / Assets
3.1%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2026-04-08 | 2025-06-30 | 2025-03-31 | 2024-06-30 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 9,615,000 |
| Gross Profit | 0 | 0 | 0 | -9,615,000 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 213,724,000 | 213,724,000 | 213,724,000 | 52,307,000 |
| Operating Expenses | 580,582,000 | 580,582,000 | 580,582,000 | 317,668,000 |
| Operating Income | -580,582,000 | -580,582,000 | -580,582,000 | -317,668,000 |
| Interest Expense | 0 | 0 | 0 | 517,000 |
| Income Before Tax | -544,173,000 | -544,173,000 | -544,173,000 | -292,171,000 |
| Income Tax Expense | 0 | 0 | 0 | 94,000 |
| Net Income | -313,154,000 | -313,154,000 | -313,154,000 | -173,414,000 |
| Per Share | ||||
| EPS | -3.84 | -3.84 | -3.84 | -2.21 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | 20,210,000 | 17,927,000 |
| Gross Profit | -20,210,000 | -17,927,000 |
| Operating Expenses | ||
| R&D Expenses | 0 | 0 |
| SG&A Expenses | 356,551,000 | 242,753,000 |
| Operating Expenses | 1,457,670,000 | 1,096,827,000 |
| Operating Income | -1,457,670,000 | -1,096,827,000 |
| Interest Expense | 1,000,999 | 1,212,000 |
| Income Before Tax | -1,328,317,000 | -1,090,542,000 |
| Income Tax Expense | 69,604,000 | -29,724,000 |
| Net Income | -744,266,000 | -687,190,000 |
| Per Share | ||
| EPS | -9.47 | -9.29 |
| EPS Diluted | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 1,488,148,000 | 3,261,057,000 |
| Short Term Investments | 3,720,185,000 | 0 |
| Net Receivables | 18,922,000 | 0 |
| Inventory | 0 | 0 |
| Total Current Assets | 5,351,323,000 | 3,424,216,000 |
| Property Plant Equipment | 52,438,000 | 59,093,000 |
| Goodwill and Intangibles | 118,399,000 | 108,905,000 |
| Total Assets | 5,527,062,000 | 3,596,722,000 |
| Liabilities | ||
| Account Payables | 0 | 0 |
| Short Term Debt | 32,198,000 | 13,847,000 |
| Total Current Liabilities | 155,327,000 | 138,704,000 |
| Long Term Debt | 17,892,000 | 29,026,000 |
| Total Liabilities | 173,219,000 | 167,730,000 |
| Shareholders Equity | ||
| Retained Earnings | -2,906,604,000 | -2,162,338,000 |
| Total Shareholders Equity | 2,854,912,000 | 2,137,384,000 |
| Balance Sheet (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 1,488,148,000 | 3,261,057,000 |
| Short Term Investments | 3,720,185,000 | 0 |
| Net Receivables | 18,922,000 | 0 |
| Inventory | 0 | 0 |
| Total Current Assets | 5,351,323,000 | 3,424,216,000 |
| Property Plant Equipment | 52,438,000 | 59,093,000 |
| Goodwill and Intangibles | 118,399,000 | 108,905,000 |
| Total Assets | 5,527,062,000 | 3,596,722,000 |
| Liabilities | ||
| Account Payables | 0 | 0 |
| Short Term Debt | 32,198,000 | 13,847,000 |
| Total Current Liabilities | 155,327,000 | 138,704,000 |
| Long Term Debt | 17,892,000 | 29,026,000 |
| Total Liabilities | 173,219,000 | 167,730,000 |
| Shareholders Equity | ||
| Retained Earnings | -2,906,604,000 | -2,162,338,000 |
| Total Shareholders Equity | 2,854,912,000 | 2,137,384,000 |
| Cash Flow Statement (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -1,328,317,000 | -1,090,542,000 |
| Depreciation & Amortization | 20,210,000 | 17,927,000 |
| Stock Based Compensation | 291,057,000 | 115,154,000 |
| Change in Working Capital | 53,509,000 | -80,394,000 |
| Operating Cash Flow | -1,019,301,000 | -1,012,818,000 |
| Investing Activities | ||
| Capital Expenditure | -7,346,000 | -1,965,000 |
| Investments | -5,818,000 | -1,965,000 |
| Investing Cash Flow | -3,550,862,000 | 1,866,000 |
| Financing Activities | ||
| Debt Repayment | 0 | 0 |
| Common Stock Issued/Repurchased | 98,379,000 | 622,406,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 2,664,613,000 | 2,636,911,000 |
| Summary | ||
| Free Cash Flow | -1,026,647,000 | -1,014,783,000 |
| Net Change in Cash | -1,772,909,000 | 1,615,822,000 |
| Cash Flow Statement (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -1,328,317,000 | -1,090,542,000 |
| Depreciation & Amortization | 20,210,000 | 17,927,000 |
| Stock Based Compensation | 291,057,000 | 115,154,000 |
| Change in Working Capital | 53,509,000 | -80,394,000 |
| Operating Cash Flow | -1,019,301,000 | -1,012,818,000 |
| Investing Activities | ||
| Capital Expenditure | -7,346,000 | -1,965,000 |
| Investments | -5,818,000 | -1,965,000 |
| Investing Cash Flow | -3,550,862,000 | 1,866,000 |
| Financing Activities | ||
| Debt Repayment | 0 | 0 |
| Common Stock Issued/Repurchased | 98,379,000 | 622,406,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 2,664,613,000 | 2,636,911,000 |
| Summary | ||
| Free Cash Flow | -1,026,647,000 | -1,014,783,000 |
| Net Change in Cash | -1,772,909,000 | 1,615,822,000 |